Posts with tag MLNM
Posted Apr 10th 2008 10:30AM by Paul Foster
Filed under: Deals
Takada Pharmaceutical Company will acquire Millennium Pharm (NYSE: MLNM) for approximately $8.8 billion through a cash tender offer of $25 per share.
MLNM closed at $16.35. MLNM over all option implied volatility of 51 is above its 26-week average of 45 according to Track Data.
M&A Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.
BloggingBuyouts is provided for informational purposes only. Nothing on the service is intended to provide personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio or securities, transaction, investment strategy or other matter. You are solely responsible for any investment decisions that you make. The contributors who provide the content of BloggingBuyouts may, from time to time, hold positions in the securities discussed at the time of writing and they may trade for their own accounts. Such holdings will be disclosed at the time of writing. By using the site, you agree to abide to BloggingBuyouts' Terms of Use.